Imaging

The Yellow III study aimed to assess the effect of evolocumab in combination with statins on plaque morphology in patients with stable coronary artery disease. In this touchCARDIO interview, we speak with Dr Annapoorna Kini (Cardiac Catheterization Laboratory, Mount Sinai Medical Centre, New York, NY, USA) to discuss the Yellow series, with focus on the […]

Evolocumab is a proprotein convertase subtilisin kexin type 9 inhibitor (PCSK9 inhibitor). When used in combination with statins, reduced plaque volume has been observed in patients with acute coronary syndrome (ACS). In this touchCARDIO interview, we speak with Dr Annapoorna Kini (Cardiac Catheterization Laboratory, Mount Sinai Medical Centre, New York, NY, USA) to discuss the use […]

As of the publication of this article, the coronavirus disease 2019 (COVID-19) infection has affected over 400 million people around the world and caused over 6 million deaths.1 Although COVID-19 infection predominantly affects the respiratory system, studies have described a wide spectrum of cardiovascular manifestations, including asymptomatic myocardial injury, myocardial infarction and myocarditis.2 Echocardiography is an easily […]

Federico Asch (MedStar Health Research Institute, Columbia, MD, USA) shares his thoughts on this year’s virtual meeting.  Speaker disclosures: Dr Asch has nothing to disclose in relation to this video. Interview and filming supported by Touch Medical Media. Interview conducted by Nicola Cartridge. Filmed during a remote video call with Dr Asch as a highlight […]

Federico Asch (MedStar Health Research Institute, Columbia, MD, USA) discusses the findings of the WASE COVID study, presented at ACC 2021. The study compared AI software-based echocardiography analysis with manual expert analysis to predict mortality based on longitudinal strain and LVEF. Abstract title: Human vs Machine Learning-based Echocardiography Analysis as Predictor of Outcomes in Acute […]

More than half of acute coronary syndromes (ACS) occur in subjects with no significant coronary stenosis.1 In view of the number of patients dying each year from a heart attack, the question of identifying these patients is of primary importance. A large body of evidence currently exists, indicating that total coronary atheroma burden (TOCAB) – the […]

Bicuspid aortic valve (BAV) represents the most common congenital cardiac anomaly, with a prevalence ranging between 1% and 2% in the general population.1 BAV is known to be associated with dilation and dissection of the ascending aorta, and the significantly higher shear forces seem to have a pivotal role on the development of such complications.2 Nowadays, patients […]

Anomalous coronary arteries originating from the opposite sinus of Valsalva (ACAOS) is one of the most clinically relevant abnormalities among the wide spectrum of coronary artery anomalies.1 Sudden cardiac death has been related to myocardial bridges, ectopic origin of the pulmonary artery, a single coronary artery and ACAOS with an intramural course (ACAOS-IM), especially in young […]

Introduction: The restriction of activation mapping to the ventricular surface of contemporary mapping systems often leads to failure to correctly identify the true site of origin (SOO) of intramural and/or sub-epicardial Vas and lower procedural success. Electromechanical wave imaging (EWI) is a non-invasive echocardiography-based high frame rate technology that offers direct transmural activation mapping and may […]